H3K9me2 Polyclonal Antibody - Citations

H3K9me2 Polyclonal Antibody - Citations

View additional product information for H3K9me2 Polyclonal Antibody - Citations (491007)

Showing 1 product Citations

Citations & References
Abstract
Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells.
AuthorsKubicek S, Gilbert JC, Fomina-Yadlin D, Gitlin AD, Yuan Y, Wagner FF, Holson EB, Luo T, Lewis TA, Taylor B, Gupta S, Shamji AF, Wagner BK, Clemons PA, Schreiber SL
JournalProc Natl Acad Sci U S A
PubMed ID22434908
Under the instruction of cell-fate-determining, DNA-binding transcription factors, chromatin-modifying enzymes mediate and maintain cell states throughout development in multicellular organisms. Currently, small molecules modulating the activity of several classes of chromatin-modifying enzymes are available, including clinically approved histone deacetylase (HDAC) and DNA methyltransferase (DNMT) inhibitors. We describe the genome-wide expression ... More